Gujarat Terce Lab Peer Comparison

BSE: 524314

₹37.75

₹-2.75 (-6.79%)

As on 17-Sep-2026IST

Market cap

₹29 Cr

Revenue (TTM)

₹46 Cr

P/E Ratio

14.1

P/B Ratio

3.1

Div. Yield

0 %

Edit

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	29	19,728	18,725	18,150	18,373
Revenue (₹ Cr)	46	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	2.09	678.07	273.51	666.92	735.15
Net Margin (%)	4.51	28.10	16.19	20.60	26.88
RoE (%)	26.36	19.73	11.15	18.75	19.16
Price to Earnings	14.07	29.65	62.98	28.19	24.99
Price-To-Book	3.08	5.37	6.97	4.50	4.17

Income Statement (₹ Cr)

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	45.62	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	46.36	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	42.35	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	3.28	796.58	478.55	1,139.61	941.63
Depreciation	0.43	78.10	126.01	281.06	57.58
EBIT	2.85	718.48	352.55	858.55	884.05
Interest	0.16	0.88	52.11	190.64	7.69
Other Income	0.74	125.96	7.37	7.45	165.62
Exceptional Items	-0.45	0.00	12.16	-17.24	-49.16
Profit before Tax	2.97	843.56	319.96	658.12	992.82
Provision for Tax	0.88	165.49	46.45	-8.80	257.67
Profit after Tax	2.09	678.07	273.51	666.92	735.15

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	9.73	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	3.88	28.74	266.35	1,392.75	91.50
Current Liabilities	10.95	385.94	848.06	2,077.10	627.48
Total Liabilities	24.55	4,037.51	3,705.61	7,246.72	4,921.88

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	5.67	1,291.22	2,525.44	5,617.77	770.28
Current Assets	14.41	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	24.55	4,037.51	3,705.61	7,246.72	4,921.88
Total Debt*	1.30	0.57	657.97	2,309.68	2.50
Net Current Assets	3.46	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	--	17.53	160.01	51.57	370.49

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	1.71	523.24	342.18	537.99	967.57
Cash Flow from Investing Activities	-0.11	-582.30	-325.92	-369.46	-561.67
Cash from Financing Activities	0.47	-46.46	13.62	-313.53	-798.31
Net Cash Inflow / Outflow	2.08	-105.52	29.88	-145.00	-392.41

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	34.83	24.97	11.43	14.47	23.39
ROE (%)	26.36	19.73	11.15	18.75	19.16
ROA (%)	8.83	18.69	7.80	9.26	14.95
EBIT Margin (%)	6.24	31.41	20.95	26.58	34.40
Net Margin (%)	4.51	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	-7.20	15.01	27.91	9.59	10.69
EBIT Growth (%)	-16.20	18.45	58.32	16.84	24.14
Net Profit Growth (%)	321.27	19.61	149.56	62.68	-9.09
EPS Growth (%)	340.36	17.73	-3.57	67.41	14.40
Book Value Growth (%)	58.76	26.75	9.67	36.71	-0.34

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	12.33	29.65	66.81	27.51	23.82
Price / Book Value	3.08	5.37	6.97	4.50	4.17
Dividend Yield (%)	0.00	0.31	0.06	0.00	1.87
EV/EBITDA	8.09	23.50	40.41	17.89	16.21
Market Cap (₹ Cr)	24.07	11,439.22	6,819.66	17,980.08	21,592.90

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.00	0.00	0.07	0.24	0.00
Short term debt to equity ratio	0.12	0.00	0.16	0.12	0.00
Current Ratio	1.32	6.70	1.31	0.74	6.06
Quick Ratio	0.98	5.59	0.88	0.53	5.31
Interest Coverage	19.33	959.59	7.14	4.45	130.11

	Gujarat Terce Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	10.67	36.10	30.84	21.07	7.07
Asset Turnover	1.93	0.63	0.48	0.45	0.52
Receivable days	38.19	121.68	113.81	63.88	26.06
Inventory Days	28.46	63.83	84.76	43.27	65.95
Payable days	57.97	108.28	101.94	151.85	81.01
Cash Conversion Cycle	8.69	77.23	96.62	-44.70	11.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.